Understudied Hyperphosphatemia (Chronic Kidney Disease) Treatment Targets and New Biological Approaches

Hyperphosphatemia is a secondary disorder of chronic kidney disease that causes vascular calcifications and bone-mineral disorders. As per the US Centers for Disease Control and Prevention, renal damage requires first-priority medical attention for patients with COVID-19; according to a Johns Hopkin...

Descripción completa

Detalles Bibliográficos
Autores principales: Anand, Ajeeta, Aoyagi, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221414/
https://www.ncbi.nlm.nih.gov/pubmed/37241191
http://dx.doi.org/10.3390/medicina59050959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221414/
https://www.ncbi.nlm.nih.gov/pubmed/37241191
http://dx.doi.org/10.3390/medicina59050959

Ejemplares similares